Related Experiment Video
Updated: Aug 17, 2026

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
Published on: May 6, 2018
Endogenous alpha2-antiplasmin does not enhance glomerular fibrin deposition or injury in glomerulonephritis
A R Kitching1, A L Turner, K-M O'Sullivan
1Center for Inflammatory Diseases, Monash University, Department of Medicine, Monash Medical Center, Clayton, Victoria, Australia. richard.kitching@med.monash.edu.au
Insights
Alpha-2-antiplasmin (alpha2-AP) does not significantly impact glomerular fibrin deposition or kidney damage in crescentic glomerulonephritis. Mice lacking alpha2-AP showed similar disease severity and fibrin accumulation compared to normal mice.
Area of Science:
- Nephrology
- Immunology
- Coagulation and Fibrinolysis
Background:
- Fibrin deposition is a key factor in glomerular injury during crescentic glomerulonephritis (GN).
- The plasminogen-plasmin system regulates fibrinolysis, balancing coagulation's role in fibrin accumulation.
- Alpha-2-antiplasmin (alpha2-AP) is a primary inhibitor of plasmin and is present in renal tissues.
Purpose of the Study:
- To investigate the role of endogenous alpha2-AP in glomerular fibrin deposition within crescentic GN.
- To determine if alpha2-AP deficiency influences the severity of immune-mediated renal injury.
Main Methods:
- Induction of crescentic antiglomerular basement membrane GN in mice with and without alpha2-AP.
- Assessment of glomerular fibrin deposition, crescent formation, and renal function (serum creatinine).
- Analysis of related proteins (plasminogen, tPA, uPA, PAI-1) and fibrinolytic activity in kidneys.
Main Results:
- Alpha2-AP was found in tubulointerstitium and glomeruli of affected mice.
- Mice lacking alpha2-AP (alpha2-AP-/-) exhibited comparable glomerular fibrin deposition, crescent formation, and renal impairment to wild-type mice (alpha2-AP+/+).
- Alpha2-AP deficiency led to enhanced renal fibrinolytic capacity without compensatory changes in key fibrinolytic proteins or activity.
Conclusions:
- Endogenous alpha2-AP does not play a significant role in net glomerular fibrin deposition in crescentic GN.
- Alpha2-AP is not critical for crescent formation or the development of renal impairment in this model of GN.
- Enhanced fibrinolytic capacity in alpha2-AP deficient mice does not prevent disease progression.
Background:
Fibrin deposition is an important mechanism of glomerular injury in crescentic glomerulonephritis (GN), a severe form of immune renal injury. Both coagulation and fibrinolysis (via the plasminogen-plasmin system) are important in net glomerular fibrin accumulation in GN. alpha2-Antiplasmin (alpha2-AP) is the major circulating inhibitor of plasmin and is expressed in the renal tubulointerstitium.
Objective:
To determine whether endogenous alpha2-AP contributes to glomerular fibrin accumulation in GN.
Methods:
Crescentic autologous phase antiglomerular basement membrane GN was induced in mice with intact and deficient endogenous alpha2-AP (alpha2-AP+/+ and alpha2-AP-/- mice).
Results:
In mice with crescentic GN, alpha2-AP was detected in the tubulointerstitium and in segmental deposits within some glomeruli. alpha2-AP+/+ mice developed crescentic GN (38 +/- 9% glomeruli affected) with glomerular fibrin deposition and renal impairment (serum creatinine 30 +/- 1 micro mol L-1, normal without GN 11 +/- 1 micro mol L-1). Genetic deficiency of alpha2-AP did not result in attenuated glomerular fibrin deposition, crescent formation (39 +/- 8% glomeruli affected), glomerular leukocyte infiltration or renal impairment (serum creatinine 33 +/- 7 micro mol L-1). alpha2-AP was unmeasurable in kidneys from alpha2-AP-/- mice, which did not develop compensatory changes in plasminogen, tissue type plasminogen activator (tPA), urokinase type PA (uPA) or plasminogen activator inhibitor-1 proteins, or changes in tPA or uPA activity. alpha2-AP-/- mice did have enhanced total renal fibrinolytic capacity as assessed by in situ fibrin overlay (alpha2-AP+/+ 0.19 +/- 0.01, alpha2-AP-/- 0.36 +/- 0.03 lyzed area/total area).
Conclusions:
alpha2-AP is not important to net glomerular fibrin deposition, crescent formation or renal impairment in crescentic GN.
More Related Videos
06:27Analysis of β-Amyloid-induced Abnormalities on Fibrin Clot Structure by Spectroscopy and Scanning Electron Microscopy
Published on: November 30, 2018
08:01The Nijmegen Hemostasis Assay: Simultaneous Fluorogenic Measurement of Thrombin and Plasmin Generation in a Single Well
Published on: February 27, 2026
Related Concept Videos
Intracellular Signaling Affects Focal Adhesions
Some...
Clot Retraction and Fibrinolysis
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Inflammation III: Local and Systemic Effects